Press Release

April 28, 2011

Final dividend 2010 Royal DSM

DSM declares dividend for 2010 of €1.35 per ordinary share of €1.50 par value.

print

Heerlen, NL, 28 Apr 2011 19:16 CEST

The DSM Annual General Meeting of Shareholders on 28 April 2011 passed a resolution to declare a dividend for 2010 of €1.35 per ordinary share of €1.50 par value. An interim dividend of €0.40 per ordinary share having been paid on 27 August 2010, the final dividend for 2010 will amount to €0.95 per ordinary share.

This final dividend of €0.95 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 2 May 2011 and the record date will be 4 May 2011.

Shareholders have from 5 May until 20 May 2011 (15.00 CET) to indicate their choice. On 20 May 2011 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.

This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 16, 17, 18, 19 and 20 May 2011. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2011 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.

The following timetable applies:

  • 2 May 2011: Ex-dividend quotation
  • 4 May 2011: Record Date
  • 5 May 2011 – 20 May 2011 (15:00 CET): Period in which shareholders can indicate their choice
  • 23 May 2011 (COB): Announcement of the exchange ratio
  • 25 May 2011: Delivery of shares or cash payment
For more information
Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420
media.contacts@dsm.com

Dave Huizing

Vice President Investor Relations
+31 45 578 2864
investor.relations@dsm.com

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864